The Filing Desk

Claritev vs Doximity

Claritev CTEV · Doximity DOCS · Health Care Technology

Claritev reported revenue of $965 million in fiscal 2025, 1.5 times Doximity's $645 million in fiscal 2026. Claritev's revenue grew 3.7% in its latest year, and Doximity's grew 13.1%. Claritev had an operating margin of 3.0%, against 33.3% at Doximity. Free cash flow was −$12 million at Claritev and $326 million at Doximity. Their fiscal years end in different months (December 31 and March 31), so the periods don't line up exactly.

Side by side

ClaritevDoximity
Latest fiscal yearFY2025, Dec 31, 2025FY2026, Mar 31, 2026
Revenue$965M$645M
Revenue growth3.7%13.1%
Revenue growth a year, last 5 years0.6%25.5%
Gross margin—89.1%
Operating margin3.0%33.3%
Net margin−29.4%30.4%
Free cash flow−$12M$326M
Free cash flow margin−1.3%50.6%
Return on capital0.5%91.3%
Net debt to EBITDA9.7x−3.3x
Dividends and buybacks$0M$432M
Change in diluted share count1.8%−1.1%
Last close$19.03$29.61
P/E at the last close—41.1×
Insider trades, last 12 monthsbought $1.9 million, sold $919,352sold $2.5 million
Piotroski F-score5 of 84 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
ClaritevDoximity
Operating margin
Percent of revenue
ClaritevDoximity
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
ClaritevDoximity

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Claritev and Doximity pages.